These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37253610)

  • 21. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.
    Yoshihara S; Tateishi U; Ando T; Kunitoh H; Suyama H; Onishi Y; Tanosaki R; Mineishi S
    Bone Marrow Transplant; 2005 Jun; 35(12):1195-200. PubMed ID: 15852024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
    Au BK; Au MA; Chien JW
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1072-8. PubMed ID: 21126596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of inhaled tiotropium add-on to budesonide/formoterol in patients with bronchiolitis obliterans developing after hematopoietic stem cell transplantation.
    Lim JU; Park S; Yoon JH; Lee SE; Cho BS; Kim YJ; Lee S; Kim HJ; Rhee CK
    Respir Med; 2023 Nov; 218():107410. PubMed ID: 37696312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Pulmonary Toxicity after Total Body Irradiation- and Busulfan-Based Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients.
    Liu KX; Poux N; Shin KY; Moore N; Chen YH; Margossian S; Whangbo JS; Duncan CN; Lehmann LE; Marcus KJ
    Transplant Cell Ther; 2022 Aug; 28(8):502.e1-502.e12. PubMed ID: 35623615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Ruxolitinib on Lung Function after Allogeneic Stem Cell Transplantation.
    Bondeelle L; Chevret S; Hurabielle C; Samy L; Goletto T; Costantini A; Sicre de Fontbrune F; Michonneau D; Socié G; Tazi A; Bouaziz JD; Bergeron A
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2115-2120. PubMed ID: 32738501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplant.
    Diab KJ; Yu Z; Wood KL; Shmalo JA; Sheski FD; Farber MO; Wilkes DS; Nelson RP
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1827-34. PubMed ID: 22766224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation.
    Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease.
    Ruhl AP; Shalhoub R; Jeffries N; Limerick EM; Leonard A; Barochia AV; Tisdale JF; Fitzhugh CD; Hsieh MM
    Ann Am Thorac Soc; 2024 Oct; 21(10):1398-1406. PubMed ID: 39189784
    [No Abstract]   [Full Text] [Related]  

  • 29. Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation.
    Nyilas S; Baumeler L; Tamm M; Halter JP; Savic S; Korten I; Meyer A; Singer F; Passweg JR; Latzin P; Stolz D
    Chest; 2018 Jul; 154(1):157-168. PubMed ID: 29275133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
    Nath K; Peterson K; Brown S; Devlin S; Rodriguez N; Barker J; Giralt S; Gyurkocza B; Jakubowski A; Papadopoulos E; Ponce D; Scordo M; Shah G; Perales MA; Sauter C; Lin A; Dahi PB
    Transplant Cell Ther; 2024 Jan; 30(1):81-92. PubMed ID: 37788792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Walther S; Rettinger E; Maurer HM; Pommerening H; Jarisch A; Sörensen J; Schubert R; Berres M; Bader P; Zielen S; Jerkic SP
    Pediatr Pulmonol; 2020 Jul; 55(7):1725-1735. PubMed ID: 32369682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation.
    McGaughey DS; Nikcevich DA; Long GD; Vredenburgh JJ; Rizzieri D; Smith CA; Broadwater G; Loftis JS; McDonald C; Morris AK; Folz RF; Chao NF
    Biol Blood Marrow Transplant; 2001; 7(5):274-8. PubMed ID: 11400949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
    Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors.
    Myrdal OH; Aaløkken TM; Diep PP; Ruud E; Brinch L; Fosså K; Mangseth H; Kongerud J; Sikkeland LI; Lund MB
    Respiration; 2022; 101(6):544-552. PubMed ID: 34937032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantation.
    Thompson PA; Lim A; Panek-Hudson Y; Tacey M; Hijazi R; Ng AP; Szer J; Ritchie D; Bajel A
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):781-6. PubMed ID: 24548876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical observation on the safety and efficacy of umbilical cord mesenchymal stem cells in the treatment of bronchiolitis obliterans after allogeneic haematopoietic stem cell transplantation.
    Li Z; Wang Y; Li G; Ma N; Li M; Yuan F; Fu Y; Wang L
    Biotechnol Genet Eng Rev; 2024 Apr; 40(1):341-358. PubMed ID: 36856529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.
    Bergeron A; Cheng GS
    Clin Chest Med; 2017 Dec; 38(4):607-621. PubMed ID: 29128013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjusting diffusing capacity for anemia in patients undergoing allogeneic HCT: a comparison of two methodologies.
    Yadav H; Torghabeh MH; Hoskote SS; Pennington KM; Lim KG; Scanlon PD; Niven AS; Hogan WJ
    Curr Res Transl Med; 2024 Jun; 72(2):103432. PubMed ID: 38244276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
    Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.